Search

everythinglearnresearchcommunity

for

Search:↓

Certain genes in Iranian sheep are linked to wool production and heat adaptation.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Menopause causes significant changes in the vaginal introitus, but less so in the labia majora, which may lead to symptoms of vaginal atrophy.

Genomic research can help improve the quality and production of natural fibers in animals.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

Certain genes and pathways are linked to the production of finer and denser wool in Hetian sheep.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Genomic profiling for myeloid cancers can find important inherited mutations, but it's challenging when these mutations aren't related to the patient's symptoms.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

Understanding normal hair growth and loss in children is key to diagnosing and treating hair disorders.

The document concludes that understanding how the skin's immune system and inflammation work is complex and requires more research to improve treatments for skin diseases.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

The research identified various cell types in mouse and human teeth, which could help in developing dental regenerative treatments.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

The article explains the genetic causes and symptoms of various hair disorders and highlights the need for more research to find treatments.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

The document concludes that mouse models are crucial for studying hair biology and that all mutant mice may have hair growth abnormalities that require detailed analysis to identify.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Minoxidil boosts hair growth by triggering growth factor release from specific stem cells.

Vitamin C helps adipose-derived stem cells grow and may support hair growth.